Cedar Hill Associates LLC cut its holdings in UnitedHealth Group Inc (NYSE:UNH) by 2.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 49,674 shares of the healthcare conglomerate’s stock after selling 1,416 shares during the period. UnitedHealth Group comprises approximately 1.7% of Cedar Hill Associates LLC’s portfolio, making the stock its 22nd biggest holding. Cedar Hill Associates LLC’s holdings in UnitedHealth Group were worth $9,728,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Beacon Investment Advisory Services Inc. grew its holdings in UnitedHealth Group by 4,073.1% during the third quarter. Beacon Investment Advisory Services Inc. now owns 48,784 shares of the healthcare conglomerate’s stock valued at $9,555,000 after purchasing an additional 47,615 shares during the period. Foyston Gordon & Payne Inc grew its stake in shares of UnitedHealth Group by 542.7% during the third quarter. Foyston Gordon & Payne Inc now owns 146,712 shares of the healthcare conglomerate’s stock valued at $28,734,000 after buying an additional 123,886 shares during the last quarter. Highbridge Capital Management LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at about $791,000. Bank of Nova Scotia Trust Co. grew its stake in shares of UnitedHealth Group by 22.3% during the third quarter. Bank of Nova Scotia Trust Co. now owns 2,568 shares of the healthcare conglomerate’s stock valued at $503,000 after buying an additional 468 shares during the last quarter. Finally, Zions Bancorporation grew its stake in shares of UnitedHealth Group by 3,795.0% during the third quarter. Zions Bancorporation now owns 5,492 shares of the healthcare conglomerate’s stock valued at $1,075,000 after buying an additional 5,351 shares during the last quarter. 86.24% of the stock is owned by institutional investors.

Shares of UnitedHealth Group Inc (NYSE UNH) opened at $225.82 on Thursday. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70. UnitedHealth Group Inc has a 1 year low of $156.49 and a 1 year high of $250.79. The company has a market cap of $218,830.00, a P/E ratio of 21.08, a price-to-earnings-growth ratio of 1.28 and a beta of 0.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The firm had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same quarter in the previous year, the firm posted $2.11 EPS. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. equities analysts expect that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.

In other news, Director William C. Ballard, Jr. sold 10,000 shares of the business’s stock in a transaction on Tuesday, January 23rd. The shares were sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the completion of the sale, the director now owns 76,637 shares of the company’s stock, valued at approximately $18,881,824.06. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Kenneth Irwin Shine sold 198 shares of the business’s stock in a transaction on Friday, January 19th. The shares were sold at an average price of $242.55, for a total transaction of $48,024.90. Following the sale, the director now directly owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The disclosure for this sale can be found here. In the last three months, insiders have sold 53,853 shares of company stock valued at $12,358,508. Insiders own 0.89% of the company’s stock.

Several analysts recently issued reports on the company. Leerink Swann reissued a “buy” rating and issued a $240.00 target price (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Cantor Fitzgerald raised their target price on UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. Oppenheimer raised their target price on UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 18th. Wells Fargo & Co reissued an “outperform” rating and issued a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Finally, Citigroup raised their target price on UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a research note on Wednesday, January 17th. Two equities research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $243.22.

COPYRIGHT VIOLATION NOTICE: This piece was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2018/02/08/unitedhealth-group-inc-unh-stake-lessened-by-cedar-hill-associates-llc.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.